title: Cross-boundary cancer studies at the University of Tokyo: Asia as a partner for Japan.
authors: please contact Hideyuki Akaza, MD, Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan. akazah@med.rcast.u-tokyo.ac.jp.
authors: Masahiko
authors: M
authors: Nishiyama
mesh_terms: D000970:Antineoplastic Agents; D001208:Asia; D002681:China; D004249:DNA Damage / Q000235:genetics; D003695:Delivery of Health Care / Q000331:legislation & jurisprudence / Q000592:standards / Q000639:trends; D055808:Drug Discovery / Q000639:trends; D019317:Evidence-Based Medicine; D006801:Humans; D007348:Insurance, Health; D007391:International Cooperation; D007564:Japan; D007883:Legislation, Medical / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy / Q000208:ethnology / Q000235:genetics; D017410:Practice Guidelines as Topic; D056910:Republic of Korea; D012955:Societies, Medical
chemical_list: D000970:Antineoplastic Agents
keywords: cancer control legislation; cancer in Asia; cross-boundary cancer studies; cross-boundary partnership; the University of Tokyo